{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:20:20Z","timestamp":1790911220622,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thrombotic microangiopathies (TMAs) are rare but can be severe in kidney transplant.<\/jats:p>\n                <jats:p>recipients (KTR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed the epidemiology of adjudicated TMA in consecutive KTR during the.<\/jats:p>\n                <jats:p>2009\u20132021 period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TMA was found in 77\/1644 (4.7%) KTR. Early TMA (<jats:italic>n<\/jats:italic>\u2009=\u200924\/77 (31.2%); 1.5% of all KTR) occurred during the first two weeks ((median, IQR) 3 [1\u20138] days). Triggers included acute antibody-mediated rejection (ABMR, <jats:italic>n<\/jats:italic>\u2009=\u20094) and bacterial infections (<jats:italic>n<\/jats:italic>\u2009=\u20096). Graft survival (GS) was 100% and recurrence rate (RR) was 8%. Unexpected TMA (<jats:italic>n<\/jats:italic>\u2009=\u200931\/77 (40.2%); 1.5\/1000 patient-years) occurred anytime during follow-up (3.0 (0.5\u20136.2) years). Triggers included infections (EBV\/CMV: <jats:italic>n<\/jats:italic>\u2009=\u200910; bacterial: <jats:italic>n<\/jats:italic>\u2009=\u20096) and chronic active ABMR (<jats:italic>n<\/jats:italic>\u2009=\u20095). GS was 81% and RR was 16%. Graft-failure associated TMA (<jats:italic>n<\/jats:italic>\u2009=\u200922\/77 (28.6%); 2.2% of graft losses) occurred after 8.8 (4.9\u201315.5) years). Triggers included acute (<jats:italic>n<\/jats:italic>\u2009=\u20094) or chronic active (<jats:italic>n<\/jats:italic>\u2009=\u200914) ABMR, infections (viral: <jats:italic>n<\/jats:italic>\u2009=\u20096; bacterial: <jats:italic>n<\/jats:italic>\u2009=\u20095) and cancer (<jats:italic>n<\/jats:italic>\u2009=\u20096). 15 patients underwent transplantectomy. RR was 27%. Atypical (<jats:italic>n<\/jats:italic>\u2009=\u20096) and typical (<jats:italic>n<\/jats:italic>\u2009=\u20092) haemolytic and uremic syndrome, and isolated CNI toxicity (<jats:italic>n<\/jats:italic>\u2009=\u20094) were rare. Two-third of biopsies presented TMA features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TMA are mostly due to ABMR and infections; causes of TMA are frequently combined. Management often is heterogenous. Our nosology based on TMA timing identifies situations with distinct incidence, causes and prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03326-8","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T12:02:26Z","timestamp":1695211346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology"],"prefix":"10.1186","volume":"24","author":[{"given":"Florent","family":"Von Tokarski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Fillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Maisons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thoreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gatault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Longuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Sautenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Buchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Fakhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"issue":"6","key":"3326_CR1","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1053\/j.ajkd.2016.10.006","volume":"68","author":"MA Lusco","year":"2016","unstructured":"Lusco MA, Fogo AB, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: Thrombotic Microangiopathy. Am J Kidney Dis. 2016;68(6):e33-4.","journal-title":"Am J Kidney Dis."},{"issue":"10095","key":"3326_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","volume":"390","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri F, Zuber J, Fr\u00e9meaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet Lond Engl. 2017;390(10095):681\u201396.","journal-title":"Lancet Lond Engl."},{"issue":"4","key":"3326_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2215\/CJN.11470918","volume":"14","author":"G Bayer","year":"2019","unstructured":"Bayer G, Tokarski F von, Thoreau B, Bauvois A, Barbet C, Cloarec S, et al. Etiology and Outcomes of Thrombotic Microangiopathies. Clin J Am Soc Nephrol. 2019;14(4):557\u201366.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"3326_CR4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","volume":"42","author":"JC Reynolds","year":"2003","unstructured":"Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis Off J Natl Kidney Found. 2003;42(5):1058\u201368.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"8","key":"3326_CR5","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","volume":"10","author":"AA Satoskar","year":"2010","unstructured":"Satoskar AA, Pelletier R, Adams P, Nadasdy GM, Brodsky S, Pesavento T, et al. De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2010;10(8):1804\u201311.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"2","key":"3326_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","volume":"18","author":"M Haas","year":"2018","unstructured":"Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2018;18(2):293\u2013307.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"7","key":"3326_CR7","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","volume":"10","author":"M Noris","year":"2010","unstructured":"Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2010;10(7):1517\u201323.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"17","key":"3326_CR8","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361(17):1676\u201387.","journal-title":"N Engl J Med"},{"issue":"7","key":"3326_CR9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.transproceed.2014.07.062","volume":"46","author":"F Nava","year":"2014","unstructured":"Nava F, Cappelli G, Mori G, Granito M, Magnoni G, Botta C, et al. Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation. Transplant Proc sept. 2014;46(7):2263\u20138.","journal-title":"Transplant Proc sept"},{"issue":"1","key":"3326_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","volume":"32","author":"N Garg","year":"2018","unstructured":"Garg N, Rennke HG, Pavlakis M, Zandi-Nejad K. De novo thrombotic microangiopathy after kidney transplantation. Transplant Rev Orlando Fla janv. 2018;32(1):58\u201368.","journal-title":"Transplant Rev Orlando Fla janv"},{"issue":"5","key":"3326_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5500\/wjt.v8.i5.122","volume":"8","author":"F Abbas","year":"2018","unstructured":"Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplant. 2018;8(5):122\u201341.","journal-title":"World J Transplant"},{"issue":"9","key":"3326_CR12","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/ajt.16717","volume":"21","author":"M Lubetzky","year":"2021","unstructured":"Lubetzky M, Tantisattamo E, Molnar MZ, Lentine KL, Basu A, Parsons RF, et al. The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2021;21(9):2937\u201349.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg."},{"issue":"10","key":"3326_CR13","first-page":"789","volume":"19","author":"C Ponticelli","year":"2006","unstructured":"Ponticelli C, Banfi G. Thrombotic microangiopathy after kidney transplantation. Transpl Int Off J Eur Soc Organ Transplant. 2006;19(10):789\u201394.","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"issue":"8","key":"3326_CR14","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.transproceed.2012.07.039","volume":"44","author":"RA Caires","year":"2012","unstructured":"Caires RA, Marques IDB, Repizo LP, Sato VAH, Carmo LPF, Machado DJB, et al. De Novo Thrombotic Microangiopathy After Kidney Transplantation: Clinical Features, Treatment, and Long-Term Patient and Graft Survival. Transplant Proc. 2012;44(8):2388\u201390.","journal-title":"Transplant Proc"},{"issue":"1","key":"3326_CR15","first-page":"131","volume":"16","author":"BH \u00d6zdemir","year":"2018","unstructured":"\u00d6zdemir BH, Ok At\u0131lgan A, Y\u0131lmaz Ak\u00e7ay E, \u00d6zdemir G, Ayvazo\u011flu Soy E, Akdur A, et al. De Novo Thrombotic Microangiopathy in Renal Transplant Patients. Exp Clin Transplant Off J Middle East Soc Organ Transplant. 2018;16(1):131\u20135.","journal-title":"Exp Clin Transplant Off J Middle East Soc Organ Transplant"},{"issue":"2","key":"3326_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","volume":"41","author":"J Schwimmer","year":"2003","unstructured":"Schwimmer J, Nadasdy TA, Spitalnik PF, Kaplan KL, Zand MS. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. Am J Kidney Dis Off J Natl Kidney Found. 2003;41(2):471\u20139.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found."},{"issue":"3","key":"3326_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41419-019-1319-5","volume":"10","author":"A Aljabri","year":"2019","unstructured":"Aljabri A, Vijayan V, Stankov M, Nikolin C, Figueiredo C, Blasczyk R, et al. HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway. Cell Death Dis. 2019;10(3):235.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3326_CR18","first-page":"784","volume":"27","author":"S Sreedharanunni","year":"2014","unstructured":"Sreedharanunni S, Joshi K, Duggal R, Nada R, Minz M, Sakhuja V. An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies. Transpl Int Off J Eur Soc Organ Transplant. 2014;27(8):784\u201392.","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"issue":"4","key":"3326_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.trim.2008.11.004","volume":"20","author":"A Beiras-Fernandez","year":"2009","unstructured":"Beiras-Fernandez A, Chappell D, Hammer C, Beiras A, Reichart B, Thein E. Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury. Transpl Immunol mars. 2009;20(4):224\u20138.","journal-title":"Transpl Immunol mars"},{"issue":"4","key":"3326_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0272-6386(96)90468-0","volume":"28","author":"BA Young","year":"1996","unstructured":"Young BA, Marsh CL, Alpers CE, Davis CL. Cyclosporine-associated thrombotic microangiopathy\/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis Off J Natl Kidney Found. 1996;28(4):561\u201371.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"4","key":"3326_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","volume":"67","author":"HM Trimarchi","year":"1999","unstructured":"Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation. 1999;67(4):539\u201344.","journal-title":"Transplantation"},{"key":"3326_CR22","doi-asserted-by":"crossref","unstructured":"Zarifian A, Meleg-Smith S, O\u2019donovan R, Tesi RJ, Batuman V. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int. juin 1999;55(6):2457\u201166.","DOI":"10.1046\/j.1523-1755.1999.00492.x"},{"key":"3326_CR23","doi-asserted-by":"crossref","unstructured":"Fortin MC, Raymond MA, Madore F, Fug\u00e8re JA, P\u00e2quet M, St-Louis G, et al. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. juin 2004;4(6):946\u201152.","DOI":"10.1111\/j.1600-6143.2004.00428.x"},{"issue":"11","key":"3326_CR24","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1681\/ASN.2012111064","volume":"24","author":"B Renner","year":"2013","unstructured":"Renner B, Klawitter J, Goldberg R, McCullough JW, Ferreira VP, Cooper JE, et al. Cyclosporine induces endothelial cell release of complement-activating microparticles. J Am Soc Nephrol JASN. 2013;24(11):1849\u201362.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"10","key":"3326_CR25","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","volume":"5","author":"H Sartelet","year":"2005","unstructured":"Sartelet H, Toupance O, Lorenzato M, Fadel F, Noel LH, Lagonotte E, et al. Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2005;5(10):2441\u20137.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"3326_CR26","doi-asserted-by":"crossref","unstructured":"Thoreau B, von\u00a0Tokarski F, Bauvois A, Bayer G, Barbet C, Cloarec S, et al. Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation. Clin J Am Soc Nephrol CJASN. sept 2021;16(9):1355\u201164.","DOI":"10.2215\/CJN.17511120"},{"issue":"3","key":"3326_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1189\/jlb.0607373","volume":"83","author":"M Schouten","year":"2008","unstructured":"Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol mars. 2008;83(3):536\u201345.","journal-title":"J Leukoc Biol mars"},{"issue":"3","key":"3326_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","volume":"129","author":"N Semeraro","year":"2012","unstructured":"Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res mars. 2012;129(3):290\u20135.","journal-title":"Thromb Res mars"},{"issue":"1","key":"3326_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1017\/S0950268807008217","volume":"136","author":"KGJ Pollock","year":"2008","unstructured":"Pollock KGJ, Young D, Beattie TJ, Todd WTA. Clinical surveillance of thrombotic microangiopathies in Scotland, 2003\u20132005. Epidemiol Infect janv. 2008;136(1):115\u201321.","journal-title":"Epidemiol Infect janv"},{"issue":"6","key":"3326_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.bmt.1703879","volume":"31","author":"H Takatsuka","year":"2003","unstructured":"Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, et al. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant mars. 2003;31(6):475\u20139.","journal-title":"Bone Marrow Transplant mars"},{"issue":"1","key":"3326_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12882-022-02672-3","volume":"23","author":"JM Halimi","year":"2022","unstructured":"Halimi JM, Thoreau B, von Tokarski F, Bauvois A, Gueguen J, Goin N, et al. What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study. BMC Nephrol. 2022;23(1):39.","journal-title":"BMC Nephrol."},{"key":"3326_CR32","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s40620-022-01465-z","volume":"36","author":"JM Halimi","year":"2023","unstructured":"Halimi JM, Al-Dakkak I, Anokhina K, Ardissino G, Licht C, Lim WH, et al. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry. J Nephrol. 2023;36:817\u201328.","journal-title":"J Nephrol."},{"issue":"4","key":"3326_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12702","volume":"6","author":"A Joseph","year":"2022","unstructured":"Joseph A, Eloit M, Azoulay E, Kaplanski G, Provot F, Presne C, et al. Immune-mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure. Res Pract Thromb Haemost mai. 2022;6(4): e12702.","journal-title":"Res Pract Thromb Haemost mai"},{"issue":"12","key":"3326_CR34","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3324\/haematol.2019.216903","volume":"104","author":"K El Karoui","year":"2019","unstructured":"El Karoui K, Boudhabhay I, Petitprez F, Vieira-Martins P, Fakhouri F, Zuber J, et al. Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome. Haematologica d\u00e9c. 2019;104(12):2501\u201311.","journal-title":"Haematologica d\u00e9c"},{"issue":"4","key":"3326_CR35","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1681\/ASN.V641160","volume":"6","author":"A Agarwal","year":"1995","unstructured":"Agarwal A, Mauer SM, Matas AJ, Nath KA. Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: current concepts and management. J Am Soc Nephrol JASN. 1995;6(4):1160\u20139.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"8","key":"3326_CR36","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","volume":"8","author":"M Le Quintrec","year":"2008","unstructured":"Le Quintrec M, Lionet A, Kamar N, Karras A, Barbier S, Buchler M, et al. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2008;8(8):1694\u2013701.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg."},{"issue":"6","key":"3326_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/MNH.0000000000000736","volume":"30","author":"JM Halimi","year":"2021","unstructured":"Halimi JM. Complications after native kidney biopsy: definitive data. Curr Opin Nephrol Hypertens. 2021;30(6):555\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"3326_CR38","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2215\/CJN.14721219","volume":"15","author":"JM Halimi","year":"2020","unstructured":"Halimi JM, Gatault P, Longuet H, Barbet C, Bisson A, Sautenet B, et al. Major Bleeding and Risk of Death after Percutaneous Native Kidney Biopsies: A French Nationwide Cohort Study. Clin J Am Soc Nephrol CJASN. 2020;15(11):1587\u201394.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"5","key":"3326_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","volume":"81","author":"DS Genest","year":"2023","unstructured":"Genest DS, Patriquin CJ, Licht C, John R, Reich HN. Renal Thrombotic Microangiopathy: A Review. Am J Kidney Dis Off J Natl Kidney Found. 2023;81(5):591\u2013605.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"3326_CR40","unstructured":"D\u00e9cret n\u00b0 2016\u20131537 du 16 novembre 2016 relatif aux recherches impliquant la personne humaine. 2016\u20131537 nov 16, 2016.\u00a0https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000033394083."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03326-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:14:51Z","timestamp":1700266491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03326-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3326"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03326-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Approval of the Ethics Committee of our institution was obtained (\u201cEspace de R\u00e9flexion Ethique R\u00e9gion Centre\u201d (Regional Ethic Space Center): research project n\u00b0 2017\u2013003) (). In France, this type of study does not require consent to participate (Jard\u00e9 law, \"Code de Sant\u00e9 Publique\", 2016, Art. L.1122\u20131-3; non interventional research)(40).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}